✦ LIBER ✦

937 Phase I trial of GL331, a novel topoisomerase-II (T-II) inhibitor for advanced refractory cancer

✍ Scribed by F.V. Fossella; R. Newman; K. Gorelick; M. Wester; A.Y. Kunz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of T138067, a Novel Micro

✍ Jordan D. Berlin; Alan Venook; Emily Bergsland; Mace Rothenberg; A. Craig Lockha 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 87 KB

Phase I-II trial of mitoxantrone (M) and

✍ L. Guistini; F. Di Costanzo; A. Sdrobolini; D. Bilancia; L. Valenti; S. Angiona; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

328 POSTER Phase II study of MTOR-inhibi

✍ M. Javle; D. Fogelman; A. Kaseb; G. Varadhachary; R. Wolff; J. Abbruzzese 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II study of XR5000 (DACA), an inhi

✍ Christian Dittrich; Veronique Dieras; Pierre Kerbrat; Cornelis Punt; Roberto Sor 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 65 KB

Phase II and pharmacokinetic/pharmacodyn

✍ Afshin Dowlati; Nathan Levitan; Nahida H. Gordon; Charles L. Hoppel; David M. Go 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 125 KB

Treatment of advanced and refractory bre

✍ F. Ries; M. Dicato 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 379 KB